Kore Private Wealth LLC Dexcom Inc Transaction History

Kore Private Wealth LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $28,181 - $35,331	217 Added 31.96%	896 $481,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $7,576 - $10,165	71 Added 11.68%	679 $371,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $161 - $215	2 Added 0.33%	608 $260,000
Q1 2021 May 18, 2021	BUY	$84.79 - $104.74 $51,382 - $63,472	606 New	606 $218,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $38,610 - $51,727	-495 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $10,028 - $16,854	160 Added 47.76%	495 $200,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $12,267 - $19,192	335 New	335 $73,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $9,326 - $13,038	-335 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$26.99 - $37.37 $9,041 - $12,518	335 New	335 $40,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.